Symrise stock holds its ground as investors await the next report

Symrise stock remains tied to its last disclosed operating figures, with the fragrance and flavor group reporting EUR 5.0 billion in sales for fiscal 2025 and an adjusted EBITDA margin of 21.7%. The company also said organic sales growth reached 7.9% in the same year, giving investors a clear baseline for the current valuation.

Fiscal 2025 sets the base

In its latest annual reporting context, Symrise said fiscal 2025 sales were EUR 5.0 billion, compared with a prior-year level that leaves the reported 7.9% organic growth as the clearest comparison point. An adjusted EBITDA margin of 21.7% shows how much of that turnover flowed through to operating profit after costs.

The numbers matter because Symrise stock is not trading on a story alone. The company built its 2025 base on multiple operating lines, and investors typically read the margin first when growth and profitability need to be weighed together.

Margin at 21.7%

Adjusted EBITDA margin of 21.7% in fiscal 2025 is the cleanest profit marker in the available data. Sales of EUR 5.0 billion and organic growth of 7.9% complete the picture and show a company that kept expanding while maintaining a double-digit profitability profile.

That combination is important for a consumer and ingredients supplier, where volume growth, pricing, and cost control can all move the margin. The 7.9% organic increase is the quantified comparison that gives the 2025 result its weight versus the prior period.

Product categories still matter

Symrise builds its business around flavors, fragrances, cosmetic ingredients, and pet food solutions, with those categories helping explain why the company can combine growth and margin discipline. For readers, the product mix matters because it spreads demand across consumer and industrial end markets.

Symrise stock therefore reflects more than one product cycle. In 2025, the group’s EUR 5.0 billion in sales and 21.7% adjusted EBITDA margin show how the portfolio translated into results that remained profitable even as the business scaled.

Price context absent

The available evidence in this call supports the company’s latest financial base, but not a current traded quote. The stock story therefore rests on the fiscal 2025 sales figure of EUR 5.0 billion, the 7.9% organic growth rate, and the 21.7% adjusted EBITDA margin.

Those three metrics are enough to anchor a factual update for Symrise stock. They show the company’s latest reported scale, its pace of expansion, and the profit rate that investors usually watch most closely.

Symrise stock fact box